To ask Her Majesty's Government what measures are in place to support the carers and family members of those people with Parkinson's disease who have experienced distressing hallucinations during the COVID-19 pandemic.
7 July 2020
As set out in the National Institute for Health and Care Excellence guideline Parkinson’s disease in adults, published in July 2017, symptoms such as hallucinations are an increased risk for people taking some Parkinson’s disease medications. The guidance sets out that people with Parkinson’s disease should have a comprehensive care plan agreed between themselves, their family members and carers and specialist and secondary healthcare providers. A copy of the guidance is attached.